May 2024
The global N95 medical protective masks market size was USD 3.26 billion in 2023, calculated at USD 3.55 billion in 2024 and is expected to reach around USD 8.25 billion by 2034, expanding at a CAGR of 8.8% from 2024 to 2034.
The global N95 medical protective masks market size accounted for USD 3.55 billion in 2024 and is expected to reach around USD 8.25 billion by 2034, expanding at a CAGR of 8.8% from 2024 to 2034.
Global N95 grade medical protective masks market is showing enormous growth in demand on account of heightening health responsiveness amid elderly population to make use of masks for escaping the viral infection. Intensifying consumer alertness for airborne contaminations has been generating a vigorous demand for these masks, most remarkably for personal usage. In this respect, a rise in epidemics of coronavirus in the recent past has been subsidizing suggestively to the need for disposable masks amid the overall public. A drift that has been absorbing the market is the accumulative use of surgical masks for individual use. The worldwide upsurge in the occurrence of air-borne diseases and contamination levels has been inspiring a substantial number of buyers to opt for disposable face masks. With consumers searching for options to retain themselves safe from viral pandemics, noticeable manufacturers are concentrating on growing their scale of operation in respects to the development of N95 grade medical protective masks for personal use.
Masks can inhibit the droplets produced through sneezing and coughing from interacting with the contiguous individual. These droplets are sufficient to spread the airborne illnesses and other contaminations. Currently, practice of mask has been augmented on account of outbreak of the Covid-19 across the globe. It has made essential to put mask every time an individual is interacting with the others. Mask averts the contaminations that can be transmitted via coughing sneezing or even speaking or approaching close in communication. Such influences are estimated to substantially fuel the demand for N95 grade medical protective masks all over the world.
Report Highlights | Details |
Market Size in 2023 | USD 3.26 Billion |
Market Size in 2024 | USD 3.55 Billion |
Market Size by 2034 | USD 8.25 Billion |
Growth Rate from 2024 to 2034 | CAGR of 8.8% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | Product Type, Application Type, End User, Region Type |
Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
Covid-19 Impact
The Covid-19 outbreak has unraveled the global supply chain for medical masks as companies such as Honeywell International and 3M are working in record time to strengthen production at home. Even with all of the augmented production, there are still not adequate N95 respirators being manufactured to house all of the medical staff and healthcare workers who require them as crucial personal protective equipment across the world. This has led to numerous concerns such as hospitals having to share N95 respirators and deliberate situations where healthcare works may want to reject emergency cure for patients affected with Covid-19 if the essential private protective equipment is not accessible. Further, demand for N95 respirators far surpassing existing manufacturing competences and continuing supply chain problems are also subsidizing to shortages. The government organizations across all nations are imposing an obligatory act of utilizing the face mask for the fortification from the communicable coronavirus. The travelers and tourists coming into the metropolises and roaming across the nations are constrained and Covid-19 testing is made mandatory for them.
On the basis of product type, the global N95 grade medical protective masks market is bifurcated into masks without exhalation valves and mask with exhalation valve. The masks lacking exhalation valves only have the coatings of strap and filter which make them cost-effective. Nonetheless, they are less favored than the masks that have exhalation valves, as they cause breathing trouble to the users.
North America is estimated to occupy the majority of the global N95 mask market revenue throughout the prediction period. The market in the region is foreseen to cultivate at a prompt pace as the citizens living in the U.S. and other regions favor wearing face masks, due to the fear of contaminations instigated by possible viruses, influenza and pollution. Europe is anticipated appear as second prevalent market through the prognosis period on account of epidemic of the Covid-19. There has been an unexpected growth in the sale for these masks, particularly in the U.S. and European nations such as Spain, Italy, and France, where the numbers COVID-19 patient have skyrocketed.
At present, biggest surgical mask producer in the U.S., Prestige Ameritech, has received a requirement of above 1.4 billion masks. CDC has commended that general public should not buy the N95 mask as it confines the supply compulsory to be deliver to healthcare personnel and to remain indoors in its place. However, the public appear to pay no attention to the directions provided by CDC and WHO which has augmented the demand for such type of masks.
Key Companies Share Insights
N95 face mask manufacturers ramps up fabrication to address the elevated Covid-19 demand in the U.S. American corporations including Honeywell, 3M, and Prestige Ameritech are capitalizing in domestic production of masks. Other companies of N95 respirators like Owens & Minor Inc. are also struggling to upsurge their manufacturing capability as they strive to keep up with the novel, unprecedented demand.
Segments Covered in the Report
By Application
By Product
By End-use
By Regional Outlook
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
May 2024
March 2024
September 2024
November 2023